1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas. 2Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, ...

A phase III study of combination therapy with everolimus plus lanreotide versus everolimus monotherapy for unresectable or recurrent gastroenteropancreatic neuroendocrine tumor (JCOG1901, STARTER-NET) ...

Patients with functional neuroendocrine tumors may experience hormone-related syndromes, such as carcinoid syndrome, characterized by flushing, diarrhea, and heart valve damage. 1 These syndromes ...

You will be redirected to our submission process. Tumor molecular pathology is an evolving field dedicated to uncovering the molecular underpinnings of cancer development and progression. This ...

Anal Cancer, Liver & Biliary Cancer, Colon Cancer, Esophageal Cancer, Gallbladder & Bile Duct Cancers, Carcinoid Tumors, Gastrointestinal Cancer, Neuroendocrine Tumors, Pancreatic Cancer Let this ...

Mechanisms of the spread of Krukenberg tumor proposed are retrograde lymphatic dissemination involved in gastric cancer metastases, hematogenous spread most frequent in colorectal cancer, and ...

This combination has “the potential to become a new standard first-line treatment” for well-differentiated grade 1/2 gastroenteropancreatic neuroendocrine tumors with poor prognostic factors ...

A brain tumor is a mass of abnormal cells that grow in the brain. Brain tumors can be benign (non-cancerous) or malignant (cancerous) and can start anywhere in the brain. Malignant tumors grow rapidly ...

58 x 43.2 cm. (22.8 x 17 in.) ...

T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited to the pancreas and size 2–4 cm T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor ...

58.4 x 43.2 cm. (23 x 17 in.) Subscribe now to view details for this work, and gain access to over 18 million auction results. Purchase One-Day Pass ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...